- Service Name
Simoa® Technology
- Industry
Biotechnology, Healthcare, Diagnostics, Biomarker Detection
- Main Value Proposition
Simoa® Technology provides researchers with the ability to detect critical biomarkers at unprecedented sensitivity, enhancing the understanding of health and disease.
- Description
Simoa® Technology is an ultra-sensitive biomarker detection platform that enables researchers to measure biomarkers at lower levels than ever before. It empowers advancements in precision health by facilitating early disease detection and improved treatment methods.
- Key Features
Ultra-sensitive protein quantitation; Wide-ranging menu of assay kits; Custom assay development services; Digital health solutions for early disease detection
- Use Cases
Research in neurology, oncology, cardiology, and infectious diseases; Development of custom assays for specialized research applications; Early detection of diseases through precise biomarker measurement
- Competitive advantages
Enhanced lot-to-lot consistency and increased lot sizes; Flexibility in custom assay development; Extensive peer-reviewed publications supporting its efficacy
- Strengths
The main strengths of Simoa® Technology include its ultra-sensitivity, versatility across various therapeutic areas, and strong scientific backing through numerous publications.
- Positioning
Simoa® Technology positions itself as a leader in ultra-sensitive biomarker detection, catering to the needs of researchers aiming to advance the science of health and disease.
- Audience
The target users include researchers in academia and industry, healthcare providers, and biotechnology companies focused on precision health.
- CTA
Explore our services
- Tags
biomarker detection
precision health
assay development
ultra-sensitivity
- Tagline
Ultra-sensitive biomarker detection to transform the future of healthcare
- Tone of Voice
Innovative, authoritative, supportive
- Differentiation
Simoa® Technology stands out in the market due to its ability to measure biomarkers at lower levels than traditional methods, enabling earlier detection and better prognoses.
- Brand Positioning
Quanterix is identified as an innovative biotechnology company committed to transforming healthcare through advanced biomarker detection technologies.
- Founded
2007-01-01
- Founders
David R. Walt